Related Experiment Video
Updated: Jul 19, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Macrolide resistance
1Department of Pharmacology, University of Wisconsin Medical School, Madison, Wisconsin 53706, USA. weisblum@macc.wisc.edu
Abstract:
The macrolides have evolved through four chemical generations since erythromycin became available for clinical use in 1952. The first generation, the 14-membered ring macrolide erythromycin, induced resistance and was replaced by the second generation 16-membered ring macrolides which did not. The inability to induce came at the price of mutation, in the pathogenic target strain, to constitutive expression of resistance. A third generation of macrolides improved the acid-stability, and therefore the pharmacokinetics of erythromycin, extending the clinical use of macrolides to Helicobacter pylori and Mycobacterium tuberculosis. Improved pharmacokinetics resulted in the selection of intrinsically resistant mutant strains with rRNA structural alterations. Expression of resistance in these strains was unexpected, explainable by low rRNA gene copy number which made resistance dominant. A fourth generation of macrolides, the 14-membered ring ketolides are the most recent development. Members of this generation are reported to be effective against inducibly resistant strains, and ketolide resistant strains have not yet been reported. In this review we discuss details of the ways in which bacteria have become resistant to the first three generations of macrolides, both with respect to their biochemistry, and the genetic mechanisms by which their expression is regulated.
Insights
Bacteria have evolved resistance to macrolide antibiotics through four generations, with mechanisms changing from inducible to constitutive resistance and rRNA alterations. Understanding these resistance pathways is crucial for developing new antibiotics.
Area of Science:
- Microbiology
- Pharmacology
- Molecular Biology
Background:
- Macrolide antibiotics, starting with erythromycin in 1952, have undergone four generations of chemical evolution.
- Early macrolides induced bacterial resistance, leading to the development of second and third generations with altered resistance profiles and improved pharmacokinetics.
- Third-generation macrolides, used for infections like Helicobacter pylori and Mycobacterium tuberculosis, selected for intrinsically resistant strains with rRNA structural changes.
Purpose of the Study:
- To review the biochemical and genetic mechanisms of bacterial resistance to the first three generations of macrolide antibiotics.
- To explain the evolution of macrolide resistance, including inducible, constitutive, and rRNA-mediated mechanisms.
- To provide insights into the development of resistance against macrolide antibiotics.
Main Methods:
- Review of existing literature on macrolide antibiotic resistance.
- Analysis of biochemical pathways involved in bacterial resistance.
- Examination of genetic regulation mechanisms of resistance expression.
Main Results:
- First-generation macrolides (erythromycin) induced resistance, which was overcome by second-generation macrolides.
- Second-generation macrolides selected for constitutive resistance through target strain mutation.
- Third-generation macrolides, with improved pharmacokinetics, led to intrinsically resistant strains with rRNA alterations, where low rRNA gene copy number facilitated resistance expression.
Conclusions:
- Bacterial resistance to macrolides is a dynamic process involving diverse biochemical and genetic strategies.
- Understanding the evolutionary trajectory of macrolide resistance is essential for guiding the development of effective antimicrobial therapies.
- The emergence of resistance highlights the need for continued research into novel antibiotic classes and resistance-breaking strategies.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Development of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Microbiota Modulation by Antibiotics
Inhibitors of Bacterial DNA Synthesis